Zobrazeno 1 - 10
of 2 024
pro vyhledávání: '"Thepen T"'
Publikováno v:
In Journal of Comparative Pathology 2004 131(1):61-69
Publikováno v:
Clinical & Experimental Allergy. Dec1992, Vol. 22 Issue 12, p1107-1114. 8p.
Publikováno v:
Immunology. Oct93, Vol. 80 Issue 2, p266-272. 7p.
Publikováno v:
Immunology. May92, Vol. 76 Issue 1, p60-64. 5p.
Autor:
Amoury, M., Mladenov, R., Nachreiner, T., Pham, A.-T., Hristodorov, D., Di Fiore, S., Helfrich, W., Pardo, A., Fey, G., Schwenkert, M., Thepen, T., Kiessling, F., Hussain, A.F., Fischer, R., Kolberg, K., Barth, S.
Publikováno v:
International Journal of Cancer, 139(4), 916-927. Wiley
Chondroitin sulfate proteoglycan 4 (CSPG4) has been identified as a highly promising target antigen for immunotherapy of triple-negative breast cancer (TNBC). TNBC represents a highly aggressive heterogeneous group of tumors lacking expression of est
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::14bdf8567ff8638deb34096b458a236c
https://research.rug.nl/en/publications/682efef5-28e7-47b4-9b7a-01596e3acb70
https://research.rug.nl/en/publications/682efef5-28e7-47b4-9b7a-01596e3acb70
Fully human MAP-fusion protein selectively targets and eliminates proliferating CD64+ M1 macrophages
Classical immunotoxins compromise a binding component (for example, a ligand, antibody or fragment thereof) and a cytotoxic component, usually derived from bacteria or plants (for example, Pseudomonas exotoxin A or ricin). Despite successful testing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______610::73a2934f959a7f21c3fdf4267505d553
https://publica.fraunhofer.de/handle/publica/246072
https://publica.fraunhofer.de/handle/publica/246072
Autor:
AYDIN KAYA, Didar1, GÜZEL, Özlem1, SEZER, Duygu2, SEVİM, Gülşen2, MATUR, Erdal3, ERGEN, Ezgi3 ezgi.ergen@iuc.edu.tr, GÜRSEL, Feraye Esen4, ATMACA, Gizem4
Publikováno v:
Kafkas Universitesi Veteriner Fakultesi Dergisi. Sep/Oct2024, Vol. 30 Issue 5, p603-610. 8p.
Autor:
Rafiei, Anahita1 (AUTHOR), Gualandi, Marco1 (AUTHOR), Yang, Chia-Lung1 (AUTHOR), Woods, Richard1 (AUTHOR), Kumar, Anil2 (AUTHOR), Brunner, Kathrin1 (AUTHOR), Sigrist, John1 (AUTHOR), Ebersbach, Hilmar1 (AUTHOR), Coats, Steve1 (AUTHOR), Renner, Christoph1,3 (AUTHOR), Marroquin Belaunzaran, Osiris1 (AUTHOR) marroquin.osiris@gmail.com
Publikováno v:
Cancers. Aug2024, Vol. 16 Issue 16, p2902. 21p.
Autor:
Sashikawa-Kimura, Miho1 (AUTHOR) sashikawa@jichi.ac.jp, Takada, Mariko2 (AUTHOR) mrktkd0711@cc.utsunomiya-u.ac.jp, Hossain, Md Razib1 (AUTHOR) razib@jichi.ac.jp, Tsuda, Hidetoshi1 (AUTHOR) thidet@jichi.ac.jp, Xie, Xiaonan2 (AUTHOR) xie@cc.utsunomiya-u.ac.jp, Komine, Mayumi1 (AUTHOR) mamitaro@jichi.ac.jp, Ohtsuki, Mamitaro1 (AUTHOR), Imokawa, Genji2 (AUTHOR) mkomine12@jichi.ac.jp
Publikováno v:
International Journal of Molecular Sciences. Aug2024, Vol. 25 Issue 16, p8737. 21p.
Autor:
Mladenov, R., Hristodorov, D., Cremer, C., Hein, L., Kreutzer, F., Stroisch, T., Niesen, J., Brehm, H., Blume, T., Brummendorf, T.H., Jost, E., Thepen, T., Fischer, R., Stockmeyer, B., Barth, S., Stein, C.
Antibody-based immunotherapy of leukemia requires the targeting of specific antigens on the surface of blasts. The Fc gamma receptor (CD64) has been investigated in detail, and CD64-targeting immunotherapy has shown promising efficacy in the targeted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______610::630ea7c6815099ba04cb944235bf3548
https://publica.fraunhofer.de/handle/publica/242020
https://publica.fraunhofer.de/handle/publica/242020